PROGRESSION-FREE SURVIVAL IN ADVANCED CLASSICAL HODGKIN LYMPHOMA PATIENTS WITH BULKY DISEASE AFTER ABVD WITHOUT RADIATION THERAPY IN ERA PET

被引：0
|
作者：
Puccini, B. [1 ]
Rigacci, L. [1 ]
Romano, I. [2 ]
Berti, V. [3 ]
Palazzo, M. [2 ]
Galli, E. [2 ]
Ciolli, G. [2 ]
Merlini, M. [2 ]
Vannucchi-, A. M. [1 ,2 ]
Nassi, L. [1 ]
机构：
[1] Careggi Hosp, Dept Haematol, Lymphoma Unit, Florence, Italy
[2] Univ Florence, Dept Expt & Clin Med, Florence, Italy
[3] Univ Florence, Dept Expt & Clin Biomed Sci, Nucl Med Unit, Florence, Italy
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D068
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [41] Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy
    Chao, Chun
    Xu, Lanfang
    Abrams, Donald
    Leyden, Wendy
    Horberg, Michael
    Towner, William
    Klein, Daniel
    Tang, Beth
    Silverberg, Michael
    AIDS, 2010, 24 (11) : 1765 - 1770
  • [42] The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
    Tizianel, Irene
    Caccese, Mario
    Torresan, Francesca
    Lombardi, Giuseppe
    Evangelista, Laura
    Crimi, Filippo
    Sepulcri, Matteo
    Iacobone, Maurizio
    Padovan, Marta
    Galuppini, Francesca
    Zagonel, Vittorina
    Scaroni, Carla
    Ceccato, Filippo
    CANCERS, 2022, 14 (16)
  • [43] Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma
    Dietrich, S.
    Weidle, J.
    Rieger, M.
    Meissner, J.
    Radujkovic, A.
    Ho, A. D.
    Dreger, P.
    Witzens-Harig, M.
    LEUKEMIA, 2014, 28 (03) : 708 - 709
  • [44] The presence of active brown fat is associated with increased overall and progression-free survival of non-Hodgkin lymphoma patients
    Crandall, John
    Koogler, Madison
    Harrod, Michael
    Parihar, Ashwin Singh
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [45] FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
    Mikhaeel, NG
    Hutchings, M
    Fields, PA
    O'Doherty, MJ
    Timothy, AR
    ANNALS OF ONCOLOGY, 2005, 16 (09) : 1514 - 1523
  • [46] Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
    Driessen, Julia
    Zwezerijnen, Gerben J. C.
    Schoeder, Heiko
    Kersten, Marie Jose
    Moskowitz, Alison J.
    Moskowitz, Craig H.
    Eertink, Jakoba J.
    Heymans, Martijn W.
    Boellaard, Ronald
    Zijlstra, Josee M.
    BLOOD ADVANCES, 2023, 7 (21) : 6732 - 6743
  • [47] Upfront Radiation Therapy Improves Progression Free Survival in Patients With Primary CNS Lymphoma
    Kim, H. J.
    Suh, C. O.
    Cho, J. H.
    Suh, Y. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E80 - E80
  • [48] Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD
    Rusconi, Chiara
    Barone, Angelica
    Visentin, Andrea
    Bianchi, Benedetta
    Zilioli, Vittorio Ruggero
    Bernardelli, Andrea
    Iadecola, Sara
    Olivari, Edoardo
    Rossi, Francesca Gaia
    Gotti, Manuel
    Cecchetti, Caterina
    Puccini, Benedetta
    Franceschetti, Silvia
    Molteni, Alfredo
    Steffanoni, Sara
    Marino, Fabrizio
    Vanazzi, Anna
    Guidetti, Anna
    Merli, Michele
    Mazzon, Federico
    Marchetti, Alfredo
    Cellini, Alessandro
    Muzi, Cristina
    Miceli, Rosalba
    Visco, Carlo
    Re, Alessandro
    Corradini, Paolo
    LEUKEMIA & LYMPHOMA, 2025,
  • [49] Brentuximab Vedotin With Chemotherapy for Stage III or IV Hodgkin Lymphoma: Impact of Cycle 2 PET Result on Modified Progression-Free Survival
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 14 - 15
  • [50] Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials: LYMPHOMA
    Broeckelmann, P. J.
    Mueller, H.
    Fuchs, M.
    Gillessen, S.
    Eichenauer, D.
    Borchmann, S.
    Robertz, A. S.
    Behringer, K.
    Welters, J.
    Ferdinandus, J.
    Boell, B.
    Tharmaseelan, H.
    Yang, X.
    Kobe, C.
    Eich, H. -t.
    Baues, C.
    Klapper, W.
    Borchmann, P.
    von Tresckow, B.
    LEUKEMIA, 2025, : 988 - 990
12345